EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Methylphenidate in the treatment of psychiatric disorders in adults: therapeutic potential and risk of misuse - a narrative review

Julia Nowosielska, Katarzyna Jaczewska, Simone Szymczyk, Kacper Król, Anna Marcinkowska, Aleksandra Płusa, Julia Nowakowska, Borys Nowosielski, Kinga Kozioł-Wójcik, Julia Nosko

Psychiatria Danubina · 17.11.2026 · 38 (3) · 249

DOI: 10.24869/psyd.2026.249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychiatria Danubina, online erschienen am 17.11.2026. Verfasst von Julia Nowosielska und 9 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Attention-deficit/hyperactivity disorder (ADHD) is a chronic neurodevelopmental condition persisting into adulthood in up to 60% of affected individuals. Adult ADHD is associated with significant functional impairment, psychiatric comorbidities, emotional dysregulation, and reduced quality of life. Psychostimulants, particularly methylphenidate, remain first-line pharmacological therapy, with decades of data supporting their safety and efficacy. Given the evolving understanding of ADHD across the lifespan, this review synthesizes current evidence on the pharmacological properties, therapeutic potential, and clinical monitoring strategies for methylphenidate and related stimulants in adults.

Methods

A narrative, concept-driven synthesis was conducted, integrating contemporary clinical knowledge, pharmacological principles, guideline-level recommendations and outcome-focused treatment principles to adult ADHD.

Results

Methylphenidate inhibits dopamine and norepinephrine transporters, increasing catecholamine availability in frontostriatal circuits responsible for attention and executive control. Its pharmacokinetic profile differs between immediate-release and extended-release formulations, allowing individualized treatment. In adults, methylphenidate is indicated for ADHD and occasionally used off-label in treatment of resistant depression or excessive daytime sleepiness. Treatment usually starts with low doses (10-20 mg/ day), which are titrated according to response and tolerability. Contraindications include uncontrolled hypertension, tachyarrhythmias, glaucoma, active psychosis and severe anxiety. Benefits include reduced inattentiveness, improved executive functioning and better occupational and psychosocial outcomes. Careful monitoring - covering cardiovascular parameters, adverse effects, potential misuse- supports safe long-term use. Across studies, psychostimulants demonstrate high efficacy and good tolerability, contributing to meaningful improvements in quality of life.

Conclusions

Methylphenidate remains a cornerstone of adult ADHD management, offering predictable pharmacological effects and flexible dosing when paired with structured clinical monitoring.

Zitieren

APA

Nowosielska, J., Jaczewska, K., Szymczyk, S., Król, K., Marcinkowska, A., Płusa, A., Nowakowska, J., Nowosielski, B., Kozioł-Wójcik, K., & Nosko, J. (2026). Methylphenidate in the treatment of psychiatric disorders in adults: therapeutic potential and risk of misuse - a narrative review. Psychiatria Danubina, 38(3), 249. https://doi.org/10.24869/psyd.2026.249

Vancouver

Nowosielska J, Jaczewska K, Szymczyk S, Król K, Marcinkowska A, Płusa A, et al. Methylphenidate in the treatment of psychiatric disorders in adults: therapeutic potential and risk of misuse - a narrative review. Psychiatria Danubina. 2026;38(3):249. doi:10.24869/psyd.2026.249

BibTeX
@article{Nowosielska2026,
  author = {Nowosielska, Julia and Jaczewska, Katarzyna and Szymczyk, Simone and Król, Kacper and Marcinkowska, Anna and Płusa, Aleksandra and Nowakowska, Julia and Nowosielski, Borys and Kozioł-Wójcik, Kinga and Nosko, Julia},
  title = {Methylphenidate in the treatment of psychiatric disorders in adults: therapeutic potential and risk of misuse - a narrative review},
  journal = {Psychiatria Danubina},
  year = {2026},
  volume = {38},
  number = {3},
  pages = {249},
  doi = {10.24869/psyd.2026.249}
}
Kostenlos starten →